# An Evaluation of a Novel Glucose Sensing Technology in Type 2 Diabetes

> **NCT02082184** · NA · COMPLETED · sponsor: **Abbott Diabetes Care** · enrollment: 302 (actual)

## Conditions studied

- Type 2 Diabetes Mellitus

## Interventions

- **DEVICE:** Sensor Based Glucose Monitoring System
- **DEVICE:** Standard Blood Glucose Monitoring

## Key facts

- **NCT ID:** NCT02082184
- **Lead sponsor:** Abbott Diabetes Care
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-03
- **Primary completion:** 2015-06
- **Final completion:** 2015-12
- **Target enrollment:** 302 (ACTUAL)
- **Last updated:** 2017-05-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02082184

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02082184, "An Evaluation of a Novel Glucose Sensing Technology in Type 2 Diabetes". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02082184. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*